SBI Pharma Fund (Equity, Sectoral)

High
18 yrs 11 monthsStarted on:14 Jul 1999
₹ 1012.75 Cras on: 22 May 2018
Long Term Horizon
2.25%
Capital Appreciation

Minimum Investment

  • ₹ 5000.00 for Lumpsum

Investment Objective

The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Exit Load

Scheme Documents

Similar Funds
Franklin Build India Fund
Return (CAGR) 16.89%
Crisil Ranking 3
Value Research
ICICI Prudential Banking And Financial Services Fund
Return (CAGR) 19.99%
Crisil Ranking NA
Value Research
SBI FMCG Fund
Return (CAGR) 16.11%
Crisil Ranking NA
Value Research NA
RELIANCE BANKING FUND
Return (CAGR) 24.34%
Crisil Ranking NA
Value Research
DSP BlackRock India T.I.G.E.R. Fund
Return (CAGR) 17.37%
Crisil Ranking 3
Value Research
UTI-Banking Sector Fund
Return (CAGR) 17.25%
Crisil Ranking NA
Value Research
HDFC Infrastructure Fund
Return (CAGR) 6.14%
Crisil Ranking 5
Value Research
Baroda Pioneer Banking And Financial Services Fund - Plan A
Return (CAGR) 13.29%
Crisil Ranking NA
Value Research
Birla Sun Life Banking And Financial Services Fund
Return (CAGR) 25.90%
Crisil Ranking NA
Value Research

Tenure

TenureReturns (CAGR)

SIP Returns

TenureReturns (CAGR)
5 YR0.12
10 YR13.91

Portfolio

Company Name% Assets
Cipla Ltd.9.84
Sun Pharmaceutical Inds. Ltd.8.35
Divi's Laboratories Ltd.8.28
Strides Shasun Ltd.6.92
Torrent Pharmaceuticals Ltd.6.16
Alkem Laboratories Ltd.5.85
Cadila Healthcare Ltd.5.37
Aurobindo Pharma Ltd.5.07
Gufic Biosciences Ltd.4.62
Aster DM Healthcare Ltd.3.52

Top Sectoral Holdings

Sector Name% Assets
Healthcare94.52

Indicators

LabelValue
Portfolio turnover ratio61
Standard Deviation14.72%

Tanmaya Desai

Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
© CRISIL Limited 2017. All Rights Reserved